Novel Insights into the Synergistic Interaction of a Thioredoxin Reductase Inhibitor and TRAIL: The Activation of the ASK1-ERK-Sp1 Pathway

2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression

(2010) Tingting Lin et al.   CARCINOGENESIS

Artificial selenoenzymes: Designed and redesigned

(2010) Xin Huang et al.   CHEMICAL SOCIETY REVIEWS

Overcoming TRAIL resistance in ovarian carcinoma

(2010) Kerri S. Bevis et al.   GYNECOLOGIC ONCOLOGY

The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells

(2010) N Goncharenko-Khaider et al.   ONCOGENE

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Protein Kinase Cα-Induced Derepression of the Human Luteinizing Hormone Receptor Gene Transcription through ERK-Mediated Release of HDAC1/Sin3A Repressor Complex from Sp1 Sites

(2008) Mingjuan Liao et al.   MOLECULAR ENDOCRINOLOGY

Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response

(2007) Kohsuke Takeda et al.   Annual Review of Pharmacology and Toxicology